Kristi Mitchell

Company: Health Equity Outcomes

Job title: CEO and Co-Founder

Bio:

Kristi is a health services researcher who leads efforts to enable next generation health care delivery through innovation, value, and consumer engagement across multiple industries, including pharmaceutical/device companies, digital health, government agencies, and community-based organizations. After 11 years, she stepped down as Practice Director, Center for Healthcare Transformation at Avalere Health, a DC-based advisory services firm to launch, Health Equity Outcomes, a nonprofit to empower underserved communities to engage in the research enterprise to reduce racial disparities and advance health equity. Through these efforts, she is dedicated to elevating the role of community-based participatory research as a mechanism to derive real world data that is community-centric. At the same time, she also serves as Founder and Principal at ATLAS CLARITY, LLC an advisory services firm dedicated to improving the health and well-being of populations through patient engagement, strategic partnerships, and innovative data collection.

Kristi is also recognized as a nationally recognized expert in the design and implementation of patient-powered data collection efforts. She currently sits on the MDEpiNet Executive Operations Committee and serves as chair of the National Kidney Foundation KidneyCARE Study Data Use and Publication Committee. Kristi is a member of Women’s Business Leaders in Healthcare, as well as a Founding Member of CHIEF-DC, a private network to support and connect women executives.
A graduate of Brown University (’92) with a A.B. in human biology and public policy, she earned her Masters of Public Health in Epidemiology and Public Health Policy and Administration from the University of Michigan School of Public Health (’94)

Seminars:

Panel Discussion: From Patient Voice to Scientific Value: How Patient Engagement Sparks Innovation 1:30 pm

Redefining engagement by clarifying what meaningful patient involvement in R&D requires structurally, culturally, and scientifically Shifting power by enabling true partnership that redistributes influence across trial design, evidence generation, and development priorities Integrating patient input early in development to improve trial design, accelerate enrollment, and generate real-world relevant evidence Centering equity in engagement strategies to…Read more

day: Day One PM